EmitBio to Present Research on Novel Light-Based Antiviral Therapy at the World Congress on Infectious Diseases

Presentation Covers Results From the Company’s Phase II Dose Finding COVID-19 Clinical Trial MORRISVILLE, N.C., Aug. 8, 2023 /PRNewswire/ — EmitBio Inc. is excited to announce its participation in the World Congress on Infectious Diseases, scheduled to take place from October 23 to 25,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.